ADMA Biologics
ADMA
$6.81
Share price
1.04%
Change (1 day)
99.12%
Change (1 year)
Categories
ADMA Biologics (ADMA) - Total assets
Total assets on the balance sheet as of December 2023 : $0.32 B
According to ADMA Biologics 's latest financial reports the company's total assets are $0.32 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
ADMA Biologics - Total assets on balance sheet (from 2010 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.32 B | -5.53% |
| 2022-12-31 | $0.34 B | 26.14% |
| 2021-12-31 | $0.27 B | 33.02% |
| 2020-12-31 | $0.20 B | 63.41% |
| 2019-12-31 | $0.12 B | 43% |
| 2018-12-31 | $88.87 M | -17.72% |
| 2017-12-31 | $0.10 B | 356.06% |
| 2016-12-31 | $23.68 M | -0.12% |
| 2015-12-31 | $23.71 M | -12.24% |
| 2014-12-31 | $27.02 M | -15.5% |
| 2013-12-31 | $31.97 M | 105.59% |
| 2012-12-31 | $15.55 M | |
| 2011-06-30 | $0 M | -29.14% |
| 2010-06-30 | $0.01 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $2.82 B | 758.01% | 🇺🇸 USA |
 Novavax NVAX | $1.79 B | 446.05% | 🇺🇸 USA |
 Cel-Sci
CVM | $28.71 M | -91.28% | 🇺🇸 USA |